Voyager Therapeutics, Inc.
VYGR
$3.77
-$0.18-4.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.89M | -33.38M | -31.02M | -34.49M | -9.04M |
| Total Depreciation and Amortization | 932.00K | 1.07M | 1.01M | 1.01M | 1.13M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.04M | 4.55M | 3.93M | 2.26M | 2.56M |
| Change in Net Operating Assets | -8.13M | -5.49M | -11.81M | 16.69M | -22.61M |
| Cash from Operations | -31.05M | -33.26M | -37.90M | -14.53M | -27.97M |
| Capital Expenditure | -207.00K | -1.11M | -658.00K | -155.00K | -258.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 35.10M | 3.04M | 41.86M | -27.05M | 64.61M |
| Cash from Investing | 34.89M | 1.93M | 41.20M | -27.20M | 64.35M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 85.00K | 513.00K | 82.00K | 574.00K | 14.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 85.00K | 513.00K | 82.00K | 574.00K | 14.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.93M | -30.82M | 3.39M | -41.16M | 36.40M |